Editorial Board


Prof. Dr. Dimiter S. Dimitrov
Center for Antibody Therapeutics, University of Pittsburgh Medical School, Pittsburgh, PA 15213, USA
Interests: therapeutic antibodies; human antibodies and their interactions; vaccine immunogens; molecular engineering; screening and sequencing methodologies; therapeutic proteins; cancer; infectious diseases
Special Issues and Collections in MDPI journals

Previous Editor

Prof. Dr. Tomohiro Kurosaki *
Former Editor-in-Chief
1 1 World Premier Institute, Immunology Frontier Research Center 9F, Integrated Life Science Building, Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan
2 RIKEN Research Center for Allergy and Immunology, Kanagawa, Japan
Interests: B lymphocyte; plasma cell; antibody; differentiation; signaling; immunological memory
* Founding Editor-in-Chief and Editor-in-Chief up to July 2014.

Editorial Board Members (100)

Prof. Dr. William R. (Bill) Strohl
Website1 Website2 Website3
Prof. Dr. Scott Alper
Department of Biomedical Research and Center for Genes, Environment, and Health, National Jewish Health; Department of Immunology and Microbiology, University of Colorado Denver School of Medicine, 1400 Jackson St., Denver, CO 80206, USA
Interests: basic immunology; inflammation; innate immunity; molecular genetics
Dr. Luis Alvarez-Vallina
Immuno-Oncology and Immunotherapy Group, Research Institute Hospital 12 de Octubre (I+12), Madrid, Spain
Interests: cancer Immunotherapy; bispecific antibodies; immunostimulatory antibodies; in situ secretion of antibodies
Dr. Adam Barb
University of Georgia, Athens, United States
Interests: antibodies; Fc gamma receptors; structural biology; N-glycosylation; NK cells; monocytes; mass spectrometry
Dr. Jagadeesh Bayry
Centre de Recherche des Cordeliers, Sorbonne Université, F-75006 Paris, France
Interests: immunology; immune homeostasis; immunotherapy; host-Pathogen interaction
Special Issues and Collections in MDPI journals
Prof. Dr. Stephen A. Beers
Antibody and Vaccine Group, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, UK
Interests: antibody drugs; Antibody immunotherapy; Cancer Immunology; Antibody Effector Functions; immunomodulatory antibodies; tumour microenvironment; Fc gamma Receptors; macrophages; antibody selection, design and preclinical development
Prof. Dr. Itai Benhar
School of Molecular Cell Biology and Biotechnology, The George S. Wise Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv 6997801, Israel
Interests: Antibody engineering; phage display antibodies; bispecific antibodies; therapeutic monoclonal antibodies; drug-carrying nanomedicines; Medicinal Chemistry; GPCR-specific antibodies; Biotechnology; Cell Biology; Antibodies; Phage Display; Cancer Research; Cell Culture; Monoclonal Antibodies; Cloning; Antigen; Recombinant Antibodies
Dr. Philippe Billiald
Institut Paris-Sud d'Inovation Thérapeutique, Université Paris-Saclay
Interests: Antibody engineering; humanization; pharmaceutical development of therapeutic antibodies; anti-thrombotic antibodies; venoms and antivenoms
Dr. Thomas Böldicke
Helmholtz-Centre for Infection Research, Structure and Function of Proteins, Inhoffenstraße 7, D 38124 Braunschweig, Germany
Interests: antibody engineering; selection of human antibodies; cancer therapy; intracellular antibodies
Special Issues and Collections in MDPI journals
Dr. Nathalie Bonnefoy
IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, 34298 Montpellier, France
Interests: Oncoimmunology; Immunotherapy; Tumor microenvironment; Tumor immunity, Therapeutic antibodies
Back to TopTop